ArticleInvestigational new drugs2017

Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II.

C M Nijenhuis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.